Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
PainReform
(NASDAQ:PRFX)
Intraday
$0.849
0.0098
[1.17%]
After-Hours
$0.849
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.849
0.0098
[1.17%]
At close: Apr 26
$0.849
0
[0.00%]
After Hours: 6:02PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for PainReform Stock (NASDAQ:PRFX)
PainReform Stock (NASDAQ: PRFX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 16, 2024
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Apr 16, 2024, 2:17PM
PainReform shares are trading lower after the company priced its $4 million public offering.
Benzinga Newsdesk
-
Apr 16, 2024, 8:26AM
PainReform Prices Offering Of 5M Shares And Warrants At $0.80/Share And Accompanying Warrant
Benzinga Newsdesk
-
Apr 16, 2024, 8:03AM
Wednesday, April 10, 2024
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Apr 10, 2024, 2:07PM
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 10, 2024, 8:12AM
Tuesday, April 09, 2024
EXCLUSIVE: PainReform's Non-Opiate Post-Surgical Pain Relief Treatment Outperforms Rival Medicine Under Various Testing Conditions
Vandana Singh
-
Apr 9, 2024, 8:30AM
EXCLUSIVE: PainReform Tells Benzinga 'Results indicated that PRF-110 released between 34%-77% more drug over a span of 96 hours under various testing conditions'
Benzinga Newsdesk
-
Apr 9, 2024, 8:30AM
EXCLUSIVE: PainReform Tells Benzinga 'Over a 72-hour industry-standard duration, and extending to 96 hours, PRF-110 exhibited remarkably higher rates of analgesic drug release compared to a market-leading post-surgical pain product'
Benzinga Newsdesk
-
Apr 9, 2024, 8:30AM
EXCLUSIVE: PainReform Tells Benzinga Co. Announces Results From New Studies Demonstrating The Superior In-Vitro Release (IVR) Rates Of PRF-110 Compared To The Industry Leader For Post-Surgical Pain Management Products
Benzinga Newsdesk
-
Apr 9, 2024, 8:30AM
Tuesday, April 02, 2024
EXCLUSIVE: PainReform Reaches 50% Enrollment Target For Phase 3 Study For Its Lead Postoperative Pain Drug
Vandana Singh
-
Apr 2, 2024, 8:00AM
EXCLUSIVE: PainReform Tells Benzinga 'In total, over 200 patients have been enrolled, of up to approximately 400 patients at eight clinical sites across the U.S.'
Benzinga Newsdesk
-
Apr 2, 2024, 8:00AM
EXCLUSIVE: PainReform Tells Benzinga 'Remains on track to announce top-line data by mid-2024'
Benzinga Newsdesk
-
Apr 2, 2024, 8:00AM
EXCLUSIVE: PainReform Tells Benzinga Co Reaches 50% Enrollment In The Second Part Of Its Phase III Clinical Trial Of PRF-110 In Bunionectomy
Benzinga Newsdesk
-
Apr 2, 2024, 8:00AM
Wednesday, December 27, 2023
PainReform Successfully Exercises Warrants For ~$1.3M In Gross Proceeds
Benzinga Newsdesk
-
Dec 27, 2023, 1:00AM
Wednesday, November 15, 2023
Painreform Provides Business Update For Q3, As Of September 30, 2023, The Company Had Cash And Short-Term Deposits Of $8.6M
Benzinga Newsdesk
-
Nov 15, 2023, 4:24PM
Monday, November 06, 2023
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Nov 6, 2023, 1:36PM
Tuesday, October 10, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 10, 2023, 1:09PM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
Friday, September 29, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 29, 2023, 2:09PM
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 28, 2023, 2:32PM
Monday, September 11, 2023
Painreform Announces Plans To Commence Second Part Of Phase 3 Clinical Trial To Evaluate PRF-110 In Patients Undergoing Bunionectomy Surgery Following FDA Review Of Drug Master File
Benzinga Newsdesk
-
Sep 11, 2023, 8:32AM
Thursday, August 10, 2023
PainReform As Of June 30, 2023, The Company Had Cash, Cash Equivalents And Short-term Deposits Of $6.2M
Happy Mohamed
-
Aug 10, 2023, 5:19PM
Friday, August 04, 2023
EXCLUSIVE: Top 10 Most-Searched Tickers On Benzinga Pro In July - See Where Tesla, Carvana, Rivian, Nikola And More Rank
Chris Katje
-
Aug 4, 2023, 2:52PM
Thursday, July 20, 2023
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Jul 20, 2023, 1:26PM
Nasdaq Down 50 Points; Tesla Earnings Beat Expectations
Lisa Levin
-
Jul 20, 2023, 9:43AM
Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jul 20, 2023, 8:04AM
Wednesday, July 19, 2023
PaiReform Regains Compliance With Nasdaq Continued Listing Requirements
Benzinga Newsdesk
-
Jul 19, 2023, 9:06AM
Monday, July 17, 2023
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Jul 17, 2023, 1:14PM
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jul 17, 2023, 8:45AM
Friday, July 14, 2023
PainReform Announces Pricing Of $1.5M Registered Direct Offering Of 166,666 Shares For $9 Per Share And Private Placement
Benzinga Newsdesk
-
Jul 14, 2023, 2:38PM
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Jul 14, 2023, 12:53PM
What's Going On With PainReform (PRFX) Stock?
Erica Kollmann
-
Jul 14, 2023, 12:06PM
PainReform Shares Resume Trades
Benzinga Newsdesk
-
Jul 14, 2023, 10:33AM
Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About
Chris Katje
-
Jul 14, 2023, 10:17AM
Dow Jumps 150 Points; JPMorgan Posts Upbeat Earnings
Lisa Levin
-
Jul 14, 2023, 10:12AM
PainReform Shares Resumed Trading
Happy Mohamed
-
Jul 14, 2023, 10:04AM
PainReform Shares Halted On Circuit Breaker To The Downside, Stock Now Up 90.6%
Benzinga Newsdesk
-
Jul 14, 2023, 9:55AM
PainReform Shares Halted On Circuit Breaker To The Upside, Stock Now Up 111.7%
Benzinga Newsdesk
-
Jul 14, 2023, 9:49AM
PainReform Shares Resume Trading
Benzinga Newsdesk
-
Jul 14, 2023, 9:48AM
PainReform Ltd. Shares Halted On Circuit Breaker To The Upside, Stock Now Up 78.1%
Happy Mohamed
-
Jul 14, 2023, 9:42AM
PainReform Shares Resume Trade
Benzinga Newsdesk
-
Jul 14, 2023, 9:39AM
PainReform Ltd. Shares Halted On Circuit Breaker To The Upside, Stock Now Up 53.4%
Happy Mohamed
-
Jul 14, 2023, 9:34AM
Wednesday, July 12, 2023
Gold Rises Over 1%; Recursion Pharmaceuticals Shares Spike Higher
Lisa Levin
-
Jul 12, 2023, 2:56PM
PainReform shares are trading lower after the company announced pricing of a $2.7 million concurrent registered direct offering and private placement.
Benzinga Newsdesk
-
Jul 12, 2023, 1:02PM
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Jul 12, 2023, 12:53PM
S&P 500 Gains 1%; US Crude Oil Inventories Increase More Than Projected
Lisa Levin
-
Jul 12, 2023, 12:13PM
Nasdaq Rises Over 1%; US Inflation Rate Falls In June
Lisa Levin
-
Jul 12, 2023, 10:01AM
PainReform Announces Pricing Of $2.7M Concurrent Registered Direct Offering And Private Placement
Benzinga Newsdesk
-
Jul 12, 2023, 9:06AM
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jul 12, 2023, 8:19AM
Tuesday, July 11, 2023
Eloxx, Airbnb, Tesla, PainReform, Roku: Why These 5 Stocks Are Drawing Investor Attention Today
Benzinga Newsbot
-
Jul 11, 2023, 8:45PM
Show more